Oculus Innovative Sciences, Inc. OCLS today announced the issuance of a new CE Mark in Europe for Microcyn-based MucoClyns™, a Microcyn-based solution intended for use in emergencies. It is safe to use on mucous membranes, cuts, abrasions, burns and body surfaces for treatment immediately after an unexpected exposure to infection risk, and before receiving professional medical attention.
"Oculus has a strong commitment to helping military personnel, fire department, police officers and all of the brave men and women called into action as first responders to safely handle unexpected infection risks, both to their patients and themselves in emergency settings," said Lori Smith, senior vice president of marketing and sales for Oculus. "MucoClyns is an easy-to-use one-step solution that helps to prevent infection and provide first responders with a clinically proven formulation that can be used in all situations since it is as safe as saline and non-flammable." Oculus is currently in discussions with potential European partners for the distribution of MucoClyns in Europe. Future consumer applications
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in